INTRODUCTION
============

Due to contamination of wounds by single-species or mi-xed populations of microorganisms leading to colonization and infection, wound healing is seriously impaired. Pre-vention and control of the microbial burden within wounds have been identified as some of the important aspects of wound management. Antimicrobial dressings, particularly silver-containing wound dressings, are widely used to control the growth of wound pathogens \[[@R1]-[@R5]\]. Silver-impregnated wound dressings have been used for treating chronic wounds and have demonstrated consistent anti-microbial activity for a diverse range of wound pathogens \[[@R6]-[@R8]\]. *In vitro* antimicrobial efficacy of various silver-based wound dressings showed varied activities against Gram-negative and -positive bacteria between species and strains. There have been many reports published on the broad-spectrum antimicrobial activity of ionic silver *in vitro* with greater activity shown against Gram-negative bacteria compared to Gram-positive organisms after 24 h of bacterial exposure \[[@R8]\]. The antimicrobial activity that exists in silver-coated wound dressings is due to silver's ability to block the energy metabolism functioning across bacterial membranes \[[@R9]\].

Novel approaches to the emerging microbial resistance to antibiotics or other disinfectants have been developed. One such approach is the application of a bioelectric field for control of wound bioburden. Procellera™ is a sterile, single layer dressing consisting of a matrix of alternating silver (Ag) and zinc (Zn) dots that are held in position on a polyester substrate with a biocompatible binder. The dressing is activated in the presence of a conductive fluid, which may come from wound exudate or exogenous fluids including saline. When activated, a direct current voltage can be recorded (0.5-0.9 volts) between an Ag and a Zn dot. Such a micro-electrical field can potentially augment the natural electric field of injury initiated following skin wounding. A physiological current is necessary for the initiation of wound healing and the transport of cells to the healing wound site \[[@R10],[@R11]\]. The microbial killing is possibly enhanced first by bioelectric field attracted microbes carrying a negative charge to the positive pole containing silver and zinc. All Gram-negative and -positive microbes carry a negative charge, and are therefore attracted to the positive pole containing silver. Silver then binds to the sulfhydryl groups of the microbes and denatures the proteins that destroy the respiratory function of the microbe as well as other essential proteins within the organism. The interaction of silver ions with thiol groups in bacterial enzymes and proteins plays an essential role in its antimicrobial action, while other cellular components, like hydrogen bonding, may also be involved. In addition, silver ions cause the release of potassium (K^+^) ions from bacteria. Hence, the bacterial plasma or cytoplasmic membrane, which is associated with many important enzymes, is an important target site for silver ions \[[@R10],[@R11]\].

Besides the specific mode of action by silver, co-impregnated zinc may contribute its antimicrobial activity by changing the cell membrane and oxidative stress to some degree as synergistic effects. It has been known that zinc (Zn^2+^) is involved in a wide variety of cellular processes, is required for maintaining the structural stability of macro-molecules, and serves as an important cofactor for other enzymes \[[@R12]\]. However, in excess zinc can inhibit the aerobic respiratory chain, can have significant toxicity, and can act as a potent inhibitor of biological systems. In prokaryotes, the major mechanisms that maintain cellular Zn^2+^ concentrations are limited to the highly regulated pro-cesses of Zn^2+^ import, metal ion sequestration by metallocha-perones and Zn^2+^ export across the cytoplasmic membrane \[[@R13]\]. Yet the molecular basis of zinc toxicity remains poorly understood. Recently, the antibacterial mechanism of zinc nanoparticle in *Campylobacter jejuni*was determined to be most likely related to disruption of the cell membrane and oxidative stress \[[@R14]\]. Due to a unique characteristic that the bioelectric current is generated by the elements such as Ag-Zn, there is also synergistic antimicrobial activity within the intrinsic properties of these elements.

In this study, we examined the *in vitro* antibacterial response to the composite bioelectric (Ag-Zn) dressing against clinically important bacterial pathogens and against drug-resistant clinical wound isolates, such as *Klebsiella pneumoniae* (ESBL), *Pseudomonas aeruginosa*(MDR), MRSA, and vancomycin-resistant *Enterococcus*species. The results of this study suggest that the combination of silver and zinc ions within a bioelectric dressing may have clinically important effects through its broad bactericidal activity; however, bacteriostatic responses with regard to *Enterococcus* species warrant further critical appraisal.

MATERIALS AND METHODS
=====================

Bacterial Isolation and Identification
--------------------------------------

The microorganisms used in this study were routinely isolated from the wounds of patients treated in the Complex Wound and Limb Salvage Center at Walter Reed National Military Medical Center (Bethesda, MD, USA) and were obtained from the wound pathogen collections in the Diagnostics and Translational Research Center (DTRC), (Gaithersburg, MD, USA). Clinical isolates, having unknown antibiotic resistance including, *Acinetobacter baumannii*(4383)*, Acinetobacter calcoaceticus* (W0041-00-CS1)*, Enterococcus faecalis*(W0044-13-CS1),*Escherichia coli*(W0041-00-CS1), *Klebsiellapneumoniae*(W0043-10-CS1),*Pseudomonas aeruginosa*(6611),*Staphylococcus aureus*(W0043-10-TS4),*Staphylococcus epidermidis*(W00-40-05-CS1), and controls, *P. aeruginosa*(ATCC 27853), and*S. aureus*(ATCC 25923) were selected and used to evaluate the antibacterial properties of the Ag-Zn bioelectric dressing. Multidrug-resistant (MDR) clinical wound isolates, *K. pneumoniae* (325, ESBL), *P. aeruginosa* (467, MDR), and methicillin-resistant*S. aureus*(507, MRSA) were studied. Clinical *Enterococcus* species, *E. faecalis* CI (4413), *E. Faecalis*(CI 543), *E. faecalis*vancomycin-resistant *enterococcus* (VRE17), *E. Faecalis*(VRE 223), *E. Faecium*(VRE 48), *E. raffinosus*(VRE 510), *E. Faecalis*(ATCC 11823)and *E. Faecalis*(ATCC 29212) were studied as well. The antibiotic resistance of these *Enterococcus* species was determined using the BD Phoenix automated microbiology system (BD Diagnostics, Sparks, MD, USA) and Spectra^TM^ VRE test (Remel, Lenexa, KS) according to the companies' procedures.

Antibiotic Susceptibility
-------------------------

For primary wound pathogens and any silver and zinc-resistant isolates, the susceptibility to appropriate antibiotics was tested on IsoSensitest agar (Oxoid, Basing stoke, UK) \[[@R5]\]. All plates were incubated at 37°C for 18-24 h. For rapid and convenient identification of *Enterococcus* species and its vancomycin susceptibility, we used a Spectra^TM^ VRE test. It is a selective and differential chromogenic medium, con-taining 6µg/mL of vancomycin, intended for use in the qualitative detection of vancomycin-resistant *E. faecium*and *E. faecalis*. According to the manufacturer's protocols, we verified the *Enterococcus* species and vancomycin suscep-tibility.

Antibacterial Efficacy Test
---------------------------

Swatches of test and control textile materials were tested qualitatively for antibacterial activity by Method 147 entitled "Antibacterial Activity Assessment of Textile Materials: Parallel Streak Method (http://www.aatcc.org.)" from the American Association of Textile Chemists and Colorists (AATCC). Those showing activities were evaluated quantitatively. Test and control swatches were inoculated with the test organisms. After incubation, the bacteria were eluted from the swatches by shaking in known volumes of neutralizing solution. The number of bacteria present in this liquid was determined, and the percentage reduction by the treated specimen was calculated. Based on the AATCC Test Method 100-2004 with some modification \[[@R15]\], the antibacterial properties of the bioelectric dressing samples, Procellera^TM^(Vomaris, Inc., Chandler, AZ, USA) (http://procellera.com/) were determined. The dressing (2" x 2" in size) contained 0.9mg/cm^2^ silver and 0.3mg/cm^2^ zinc. All pathogens studied were streaked onto tryptic soy agar (TSA) (MP Biomedicals, Solon, OH, USA) plates. On the next day, a single colony from each culture was inoculated into tryptic soy broth (TSB)(MP Biomedicals, Solon, OH, USA). After overnight incubation at 37°C, these logarithmic growth phase cultures were diluted (1:1,000 or 1:10,000) into fresh TSB to achieve an approximate concentration of 4x10^5^colony forming units (CFUs)/mL. The true concen-trations were determined by two methods including colony counts on agar plates and the spectrophotometric measu-rement of the optical density (OD) at OD600nm. The con-centration was added to the 4.8cm-diameter dressings (or equivalent to 2" x 2" Procellera^TM^). Controls included untreated dressing samples which did not contain silver and zinc, fresh TSB applied directly onto a bioelectric dressing sample, and bioelectric dressing samples plated at "0" contact time (plated as soon as possible after inoculation). The bioelectric dressing samples and control samples were incubated in a volumetric flask at 37°C for 24 h. At the end of the incubation period, the samples were quenched with 100mL PBS supplemented with sodium thioglycolate as a neutralizing solution. Flasks were shaken vigorously for 1 min and serial dilutions of the eluents were made in 0.85% normal saline solution. Then each dilution was plated onto TSA plates and incubated at 37°C for 24 h. The next day viable bacteria were counted. The percentage reduction in the bacterial load was calculated by the following formula:

\% bacterial reduction = 100(B-A)/B.

where A is the CFUs of bacteria recovered from the inoculated bioelectric dressing samples incubated for 24 h, and B is the CFUs of bacteria recovered from the inoculated bioelectric dressing sample at "0" contact time (or inoculated non-silver and zinc coated sample at "0" contact time) incubated for 24 h. The percentage reduction was also converted to the log~10~ reduction values, which represent the antimicrobial effect of the silver and zinc in the dressing. Then they were calculated as the difference between the log~10~ values of the starting and surviving numbers of microorganisms. Bactericidal activity was defined as a reduction of greater than 10^3^ CFU in a 10^5^ CFU/mL inoculum. For the prolonged antibacterial efficacy test, the bioelectric dressing samples treated with *Enterococcus* clinical wound isolates showing a bacteriostatic activity were incubated at 37°C for 0, 24, and 48 h. All experiments were carried out in three independent assays.

Detection of Silver Resistance Genes
------------------------------------

To investigate whether any of the strains carried genes encoding silver resistance (*sil*E, *sil*P and *sil*S), a colony PCR assay for silver-resistant colonies with *sil*E (0.4 kb), *sil*P (2.5 kb), and *sil*S (1.5 kb) primer sets was performed \[[@R5],[@R16]\]. Templates were prepared by heating a bacterial suspension at 95°C for 10 min. Each PCR reaction contained 2μL template DNA, 0.4μL respective primer pair and 1μL Taq DNA polymerase (New England Biolabs, Ipswich, MA, USA) for a total reaction volume of 20μL.

The mixtures were processed in a Bio-Rad cycler, consisting initial denaturation at 95°C for 2 min, followed by 40 cycles of 1 min at 95°C, 1 min at 55°C, and 3 min at 72°C. The final extension step was performed at 72°C for 5 min. As positive and negative controls, *Enterobacter cloacae*ATCC 13047 (carrier of the complete *sil* gene complex) and dH~2~O were included. Each DNA sample was run twice. Ten μL of each PCR reaction was analyzed on a 1.2% agarose gel. After electrophoresis was completed, the gel was photographed and the bands were analyzed.

Statistical Analysis
--------------------

Data were expressed as mean ± standard deviation. Statistical comparisons were performed using as a two-tailed t-test assuming equal variances, where P-values \<0.05 were considered statistically significant.

RESULTS
=======

Characterization of Wound Pathogens
-----------------------------------

Clinical wound isolates having unknown antibiotic resistance were selected and used to evaluate antibacterial properties of the Ag-Zn bioelectric dressings (Fig. **[1](#F1){ref-type="fig"}**). Next, to determine antibacterial efficacy against the antibiotic-resistant clinical wound isolates we selected the MDR, ESBL, and MRSA (Fig. **[1](#F1){ref-type="fig"}**). Furthermore, to determine whether this wound dressing has bactericidal or bacterios-tatic activity against other *Enterococcus* species, clinically relevant *Enterococcus* species were tested, as shown in Fig. (**[2](#F2){ref-type="fig"}**) and Table **[1](#T1){ref-type="table"}**.

Multidrug-resistant clinical isolates and vancomycin resistance of these *Enterococcus* species were identified by the BD Phoenix automated microbiology system. The resistance of all the *Enterococcus* species tested in this study was verified again using a commercial identification kit, Spectra^TM^ VRE test. The system is designed for *E. faecalis* and *E. facieum* strains. Each strain shows a blue or pink color when it is grown on the agar plate. As expected the *E. faecalis* and *E. faecium* VRE isolates fully grew (blue and pink, respectively) on the assay plates containing 6 μg/mL vancomycin, indicating that they are resistant to vancomycin. Other isolates (*E. facalis*CI 4413, *E. faecalis* CI 543 isolates, and even controls such as *E. faecalis* ATCC 11823 and *E. faecalis* ATCC 29212 strains) showed partial growth in blue, indicating that they have a MIC≥6μg/mL and possibly have intermediate sensitivity or are sensitive to vancomycin. Later it was determined to be sensitive to vancomycin based on the BD Phoenix instrument. No *E. raffinosus*isolate was grown up to 48 h incubation (data not shown). Most of the *Enterococcus* strains were shown to be vancomycin-resistant, although the susceptibility of these strains varied.

Antibacterial Efficacy of a Bioelectric Wound Dressing
------------------------------------------------------

Except for the *E. faecalis* isolates, all types of clinical bacterial isolates were killed completely within 24 h of exposure to the bioelectric wound dressing (Fig. **[1](#F1){ref-type="fig"}**). We selected several multidrug-resistant strains, such as *K. pneumonia* MDR, MRSA and *P. aeruginosa* MDR. All of these MDR strains had shown a 100% reduction at 24 h, indicating the dressing has broad-spectrum bactericidal activity (Fig. **[1](#F1){ref-type="fig"}**). Eight additional clinical *Enterococcus* species including VRE isolates were selected, and the antibacterial efficacy of the dressings against these species was extensively examined (Fig. **[2](#F2){ref-type="fig"}** and Table **[1](#T1){ref-type="table"}**). Unexpec-tedly, the results showed approximately 100-fold increases at 24 h compared to the starting inoculum applied to the bioelectric dressing at 0 h (approximately 4 x 10^5^ CFU/mL). It was determined that the effect of the bioelectric dressing against most of the VRE clinical isolates was bacteriostatic at 24 h having almost similar bacterial survival rates (Fig. **[2](#F2){ref-type="fig"}** and Table **[1](#T1){ref-type="table"}**).

Prolonged Incubation with the Wound Dressing Treatment
------------------------------------------------------

Potential bacteriostatic *Enterococcus* isolates at 24 h were tested to determine how such isolates would react to longer incubation times of up to 48h. Each bacterial culture was applied to bioelectric wound dressings. The cultures were then incubated at 37°C for 24 or 48 h, respectively. After 24 or 48 h incubation, colonies were counted to calculate antibacterial efficacy. All the *Enterococcus*bacterial isolates had slightly decreased growth at 48 h compared with those exposed to the bioelectric wound dressing for 24 h. However, an *E. raffinosus*VRE isolate showed no growth, and 100% bacterial reduction within 48 h. The data showed that the bioelectric wound dressing could have a specific bactericidal activity against the *E. raffinosus* VRE isolate. Percival *et al*. \[[@R15]\] showed that all strains were killed following a maximum of 48 h of exposure to the dressings. However, in this study, most of the *Enterococcus* species, with the exception of *E. raffinosus* VRE, showed no significant response (antimicrobial effect) to the bioelectric wound dressing even up to 48 h (Fig. **[2](#F2){ref-type="fig"}** and Table **[1](#T1){ref-type="table"}**). Although bacteriostatic activity was evident at 24 h for *E. raffinosus* VRE, prolonged incubation up to 48h was effective in 100% killing with the dressing exposure. This difference may have resulted due to the generally slow bacterial growth rate of *E. raffinosus* VRE isolate, such that antibacterial activity of the dressing may be time dependent.

PCR Analysis for Detection of Silver-Resistant genes
----------------------------------------------------

To determine any associations with the known silver-resistant proteins, we tested the presence of silver-resistant genes in *Enterococcus*isolates in PCR analysis. None of the PCR products representing the silver-resistant genes were found in any of the tested organisms, except the *E. cloacae*control strain which was found to possess all three genes (data not shown).

DISCUSSION
==========

This study was designed to assess the *in vitro* antibacterial activity of an advanced wound care bioelectric (Ag-Zn) dressing. Quantitative antibacterial *in vitro* testing was used to conduct this investigation. The bioelectric wound dressing showed a good bacterial killing activity against Gram-negative and -positive bacteria as shown in Fig. (**[1](#F1){ref-type="fig"}**). Because of the initial bacteriostatic activity observed against the *E. faecalis* clinical isolate (Fig. **[1](#F1){ref-type="fig"}**), eight additional clinical *Enterococcus* species were selected and examined for their antibacterial efficacy. Unexpectedly, the results showed approximately 100-fold increases at 24 h and subsequently 10-fold reduction at 48 h compared to the starting inoculum at 0 h (approximately 4 x 10^5^ CFU/mL) that was applied to the bioelectric dressing. Enterococci tested after 24 h exposure to the wound dressing showed an increase of approximately 1 x 10^7^ CFU/mL, indicating the prevalence of (Ag-Zn) resistance in *Enterococcus* species. This resistance might be due to intrinsic characteristics in cell wall and membrane to some degree (Fig. **[2](#F2){ref-type="fig"}** and Table **[1](#T1){ref-type="table"}**). In the comparative antimicrobial efficacy studies of various wound dressings, it was reported that a certain type of MRSA and *B. subtilis* among *S. aureus*, *P. aeruginosa*, and *E. coli* are less sensitive to the tested antimicrobial dressings \[[@R17]\]. It suggests that some dressings have a narrower range of bactericidal activities against both Gram-positive and -negative bacteria, but others exert a broad spectrum of action because the activity of the agents impregnated in wound dressings may vary depending on the total amount, method of impregnation, dressing properties and sustained availa-bility. Additionally, results may be influenced by dressings binding with components of wound fluid, negating its antimicrobial attributes during clinical use \[[@R18]\]. Never-theless, some particular dressings may be less sensitive to multidrug-resistant and/or (Ag-Zn)-resistant bacteria. Future extensive studies are planned with prolonged incubation up to 7 days and application of various comparable wound dressings including either Ag or Zn or both, as tested in the present study. In the case of *E. raffinosus* VRE, this species had an approximately 1 x 10^5^ CFU/mL at 24 h (Table **[1](#T1){ref-type="table"}**). Surprisingly, the bioelectric wound dressing showed bac-teriostatic activity at 24 h incubation to *E. raffinosus*, but it had bactericidal activity at 48 h. *E. raffinosus* VRE only had bactericidal activity, which may be due to its slow growth. Therefore, gene expression levels of other *Enterococcus*isolates and the *E. raffinosus* VRE isolate may be a topic for further investigation.

Enterococci, Gram-positive lactic acid bacteria, are prevalent in the environment, and are an important source of nosocomial infections, as well as wound infections and endocarditis. Certain enterococcal strains, such as *E. faecalis*and *E. faecium*, are becoming increasingly harmful to people with weakened immune systems since bacteria within such individuals are intrinsically resistant to many antibiotics including cephalosporins, quinolones, clindamycin, and can easily acquire additional antimicrobial resistance. At present, the increasing occurrence of VRE is a particularly important clinical concern, as effective antibiotic treatment can be difficult to achieve. Therefore, understanding resistance to antibiotics and biocides is a topic of major significance. Vancomycin-resistant clinical isolates of *Enterococcus* species are now commonly diagnosed in clinical micro-biology laboratories. In contrast to *Enterococcus* spp., *S. aureus* isolates are susceptible to vancomycin. There is growing concern that there is emerging vancomycin resistance for this bacterial species \[[@R19]\]. Recently, several cases of high-level resistance to vancomycin among *S. aureus* (VRSA, MIC≥16µg/mL) and vancomycin-inter-mediate *S. aureus* (VISA, MICs 4-8µg/mL) were reported \[[@R20]-[@R22]\]. Our future studies will focus on the *in vitro* antibacterial efficacy test against VISAs and VRSAs using several types of wound dressings, including the one tested in this study.

As Silver \[[@R23]\] suggested, the widespread and uncontrolled use of Ag^+^ in wound care may result in more bacteria developing resistance. Furthermore, Li *et al*. \[[@R24]\] described Ag^+^-resistant clinical *E. coli* isolates, selected by step-wise exposure to higher concentrations of Ag^+^, demonstrating active efflux of Ag^+^. In our study, we found *in vitro* bacteriostatic activity against several *Enterococcus*species, indicating the bacterial evolution to silver resistance (Fig. **[2](#F2){ref-type="fig"}** and Table **[1](#T1){ref-type="table"}**). The activity is not directly derived from the genes encoding either silver or zinc resistance. However, it might be from the genes capable of altering cell membrane rigidity and integrity, because in the PCR analysis for detecting the known silver-resistance genes, no PCR products were produced except for *E. cloacae* ATCC 13047 as a control (data not shown), indicating no presence of *sil* genes in the *Enterococcus* isolates investigated. The existence of a silver-resistance gene (*silE*) in MRSA and MR-CNS did not provide protection to the organism with a silver-containing hydro-fiber wound dressing \[[@R25]\]. To date, no MRSA strains have been found to possess silver-resistance genes. Such a result gives reason to believe that the resistance of *Enterococcus* species to (Ag-Zn), which is impregnated in the bioelectric wound dressing, might be due to tight regulation or changes in structure of influx and efflux processes necessary to maintain the intracellular level of the heavy metal ions. Overall, these results indicate that the (Ag-Zn)-resistant *Enterococcus* species might develop tolerance through other mechanisms.

Currently, there is no known, common mechanism of bacterial resistance to all heavy metal ions. Usually, the genes encoding resistance to heavy metals are located either on the chromosome, on the plasmids, or on both in bacteria. Bacteria have evolved mechanisms utilizing a number of proteins, such as ion transporters, reductases, glutathione-related cadystines, cysteine-rich metallothioneins, and low-molecular-weight cysteine-rich metal ligands to regulate the influx and efflux processes necessary to maintain the intracellular level of the heavy metal ions \[[@R26]\]. According to a recent publication, most silver-resistant bacterial strains have developed tolerance by utilizing an Ag^+^ATPase efflux pump and anti-porters rather than chemical detoxification mechanisms in which the genes encoding for copper-silver efflux outer membrane protein, and periplasmic copper and silver binding proteins were up-regulated when the bacteria were exposed to silver nanoparticles \[[@R4]\]. The work indicated that multiple antibiotic resistance genes may also play a role in the evolution of silver resistance in *E. coli*. Recently, to understand the molecular basis for the high zinc resistance, Xiong *et al*. \[[@R27]\] performed whole genome sequencing and identified nine putative Zn^2+^ transporters with four *znt*A-like genes among them being all induced by Zn^2+^ and ZntR1 (a regulator for transcription of *znt*A1). Due to the lack of understanding of silver or zinc regulation in the *Enterococcus* species, current research efforts are focused on finding genes up-regulated and down-regulated under (Ag-Zn) exposure in order to understand how these *Enterococcus* species cope with either Ag or Zn, or both in environmental stresses.

Through extensive characterization of the (Ag-Zn)-resistant mutants of *Enterococcus* species, or through further selection by stepwise exposure of both sensitive and resistant strains to either AgNO~3~, ZnCl~2~, or in combination with both species, any enhanced efflux of (Ag-Zn) ions will be examined to see if (Ag-Zn)-resistant mutants are found. We hypothesize that (Ag-Zn) resistance in *Enterococcus* species may depend on the activation of endogenous silver and/or zinc efflux systems while providing the basis for (Ag-Zn) resistance, as described in *Candida albicans*\[[@R28]\]. Future studies are planned to pursue and identify the mechanism of (Ag-Zn) resistance and the stability of the resistance phenotype in the absence of (Ag-Zn) selection pressure.

CONCLUSION
==========

The effective bactericidal activity of a bioelectric wound dressing was shown against antibiotic-sensitive strains and multiple antibiotic-resistant strains of wound pathogens, but *Enterococcus* species including VRE strains are bacteriostatic when exposed to the wound dressing. We hypothesize that (Ag-Zn) resistance in *Enterococcus* species may depend on the activation of endogenous silver and/or zinc efflux systems while providing the basis for (Ag-Zn) resistance.
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![Antibacterial properties of the bioelectric wound dressing showing log10 reduction in CFU of bacteria after 24 h exposure against various clinical wound isolates. The numbers of the bioelectric wound dressing treated bacteria at 24 h were significantly lower when compared to the control treated at 0 hour (\*P \< 0.05) as denoted with asterisk. Data reported are the average values of three independent assays. The results are shown as means the standard error on the mean of three experiments.](TOMICROJ-8-15_F1){#F1}

![Prolonged incubation up to 48 hours showing the antibacterial properties of the bioelectric wound dressing against Enterococcus clinical wound isolates. Data reported are the average values of three independent assays. The results are shown as means the standard error on the mean of three experiments.](TOMICROJ-8-15_F2){#F2}
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*Enterococcus* clinical isolates from wounds, antibiotic resistance, and antibacterial efficacy to the bioelectric wound dressing.

  Bacteria                   Vancomycin Resistance   Survival Rate (CFU/mL)   Antibacterial Efficacy   
  -------------------------- ----------------------- ------------------------ ------------------------ -------------------------
  24 h                       48 h                                                                      
  *E. faecalis* CI 4413      sensitive               \~5 x 107                \~5 x 106                Bacteriostatic activity
  *E. faecalis* CI 543       \~5 x 107               \~1 x 107                                         
  *E. faecalis* VRE 17       resistant               \~1 x 106                \~1 x 107                
  *E. faecalis* VRE 223      \~1 x 107               \~5 x 106                                         
  *E. faecium* VRE 48        \~5 x 107               \~5 x 106                                         
  *E. raffinosus* VRE 510    \~1 x 105               0                        Bactericidal activity    
  *E. faecalis* ATCC 11823   sensitive               \~5 x 107                \~1 x 107                Bacteriostatic activity
  *E. faecalis* ATCC 29212   \~5 x 107               \~5 x 106                                         
